@johndprent doesn't fact check anything for IMU. If it's seen as a negative, he will just fire away. He doesn't even know about the ATO's R&D rebate for clinical trial done oversea when he could have just Google them and somehow think IMU has been conducting all their clinical trial in Australia which is why they've been able to claim the 43% R&D rebate in the previous financial years. @dory level thinking there......
IMU Price at posting:
2.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)